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The  scope  of  serologic  investigations  on  varicella  and  herpes  zoster  has 
been limited by the lack  of an  overtly susceptible  animal  or of a  means of 
propagation of the viruses. The only source of antigen for immunologic studies 
has been the contents of the vesicular lesions present in the infected individual. 
In spite of this handicap, vesicle material has been employed as a complement- 
fixing antigen by a  number of workers, among the most recent being Netter 
and Urbain (1) and Brain (2). Amies (3, 4), in addition, used vesicle fluids as 
a source of elementary bodies for microagglufination tests. 
With  the development of procedures for the propagation of the varicella- 
zoster viruses in vitro (5), it seemed probable that human cells in culture would 
suffice for the detection of virus in neutralization tests, as well as providing a 
convenient source of antigen. However, the unusual cytopathic pattern of the 
agents did not permit direct application of the serologic techniques then in 
use.  As  an  alternative,  the fluorescent antibody method was  applied  to  the 
examination of infected tissue culture preparations (6). Employing the infected 
preparations as antigen, fixation of antibody from human sera obtained from 
cases of varicella and of herpes zoster was detected by the use of a fluorescent 
antihuman  gamma  globulin conjugate. 
Further experience now has accumulated on the in vitro propagation of vari- 
cella-zoster viruses; this experience is detailed in an accompanying paper (7). 
Experiments leading to the development of a  complement-fixation test utiliz- 
ing antigens prepared from infected cultures and of an in vitro neutralization 
technique are described in the present report. Data, derived from the applica- 
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tion  of  these  methods,  indicating  the  temporal  distribution  of  the  antibody 
response  and  beating  on  the  antigenic  relationship  of  the  varicella  (V)  and 
zoster  (Z)  agents  are  also  presented. 
Materials and Methods 
Tissu~ Culture Tevhniques.--The techniques of cultivation of the V and Z agents have been 
detailed (7). In the immunologic studies human embryonic skin-muscle (SM) tissue was used 
almost exclusively for the preparation  of cultures in view of the profuse growth obtained 
therewith. Heavily explanted cultures maintained on Enders' bovine amniotic fluid medium 
(8) usually developed confluent sheets of outgrowth in 10 to 20 days which covered most of 
the surface of the tube or bottle; provided that active tissue growth was continuing, the cul- 
tures were then ready for use. A convenient indicator of continuing growth was the appearance 
in the cultures,  24 to 48 hours after a  change of nutrient,  of large numbers of  "rounded" 
fibroblast-like cells undergoing mitosis. 
Virus Strains.--The several strains of V and Z virus, herein referred to by code letters, 
i.e., Wd. V or Blu. Z, were isolated from vesicle fluid specimens in tissue culture and  main- 
tained  by serial propagation  in vitro; pertinent  clinical data  concerning these strains  and 
their cultivation has been reported (7). In view of the unusual behavior of the agents in vitro, 
the virus material for neutralization tests consisted of a suspension  of infected cells as contained 
in the freshly harvested cell sheet from cultures showing characteristic cytopathic  changes; 
often the suspension  was an aliquot of the inoculum prepared  for routine  subculture of  a 
strain of virus. 
S~ra.--Spedmens of serum were stored in the frozen state at -20°C. Prior to use in serologic 
studies, the sera were inactivated as routine at 56°C. for 30 minutes. For neutralization tests, 
specimens were first diluted  1:2 in isotonic phosphate buffered saline  (pH  7.1-7.2)  and in 
the CF test inactivation was usually done after a  1:2 dilution had been prepared in veronal 
buffer.  The sera are identified as to clinical entity and dated with reference to the onset of 
illness which was arbitrarily recorded as the day of appearance of the exanthem. 
Complement Fixation; Method and Materials.--The  micro method of Fulton and Dumbell 
(9),  as modified by Svedmyr, Enders, and Holloway (10)  in a  complement-fixation test for 
poliomyelitis, was used as routine. Glassware in the test was cleaned with H~SO,-diehromate 
solution and kept separate from the general tissue culture supply. Water was redistilled in 
glass. The diluent was 0.85 per cent saline containing calcium and magnesium ions and buffered 
with veronal to a pH of 7.4-7.6 (11); this was prepared as a stock solution, autoclaved, stored 
at 4°C., and diluted 1:5 for use. 
ttemolytic system: Sheep erythrocytes were obtained in Alsever's solution and stored at 
4°C. These were washed three times in buffer, centrifuged at 1500 R.r.~. for 10 minutes, and 
a 0.4 per cent suspension of the packed cells prepared for use.  Antisheep hemolysin was ob- 
tained commercially. The hemolysin was titrated by the drop method on plates and cells were 
sensitized by incubation of equal volumes of 0.4 per cent red cells and a dilution of hemolysin, 
containing 1 hemolytic unit per standard drop, at 37°C. for 1 hour. 
Complement: Pooled guinea pig sera stored in the CO2 cabinet in sealed ampoules were the 
source of complement. Two units,  (unit is least amount giving complete hemolysis) as de- 
termined by pretitration, were used, and the exact amount established by concurrent retitra- 
tion in each test. It was noted that certain of the lucite plates induced variation per se into 
the test; therefore a complement titration often was done on each plate utilized in an experi- 
ment. 
Antigens: The preparation  of the various antigens is described below. Concentration by 
ultrafiltration, when indicated, was carried out at 4°C. by the method of Seibert (12) as modi- T. H.  WELLER  AND  H.  M.  WITTON  871 
fled by Svedmyr and coworkers (10). Complement and heated antigens were titrated as rou- 
tine in a block titration, and antigens used in a dilution su~dent to eliminate any residual 
anticomplementary activity. 
Controls: The usual controls were set up in each test, including the antigen in the appropriate 
dilution, and each serum in a  1:4 and 1:16 dilution. 
Method o/reading: Absent or minimal hemolysis was recorded as -{-, and hemolysis from 
this level to an estimated 50 per cent as 4-; hemolysis in excess of an estimated 50 per cent 
was recorded as negative. 
Neulralization Techn~ue.--Ttds is described below. 
EXPEI~ra¢~NTAL 
The Preparation of a Complement-Fixing Antigen from tke Fluid 
Phase of Tissue Cultures Infected witk tke VariceUa-Zoster 
Viruses 
Preliminary  Sludies.--A  series  of  complement-fixation  (hereafter  termed 
CF) tests were pedormed with antigens consisting of pooled fluids as routinely 
harvested from cultures infected with the V-Z viruses. The fluids were obtained 
from cultures showing extensive  specific degeneration between the 21st  and 
35th day after inoculation.  The antigens were heated 30 minutes at 60°C. and 
diluted 1:2 with veronal buffer for use. When paired V or Z sera were tested 
with these antigens, 4- to 32-fold rises in titer of CF antibody occasionally 
were demonstable; there was considerable  variation in antigenic potency of 
individual fluid pools, and the level thereof was low. Therefore, attempts were 
made to prepare concentrates of the routine fluids by ultrafiltration; the ma- 
terials therein---/.e.,  serum and embryo extract--provided an anticomplemen- 
tary product that did not yield to heat treatment. The solution to this problem 
as utilized by Svedmyr et al. (10) was not applicable, namely, the substitution 
of a maintenance medium at the time of introduction of poliomyelitis  virus. 
We had noted that the V-Z viruses  failed to produce  progressive  cytopathic 
changes in cultures maintained on a  simple serum-ultrafiltrate balanced salt 
solution medium (7). 
Modification of Cultural Procedures/or  Antigen Production.--Bottle cultures 
of human embryonic SM tissue were then employed. After profuse growth had 
become  established,  the bottles were heavily inoculated with suspensions  of 
tissue prepared from infected roller cultures.  Regular medium in 20 to 25 ml. 
amounts was supplied with changes at 3 to 5 day intervals until specific focal 
cytopathic lesions were well established  as observed  with a dissecting  micro- 
scope. Thereafter, the serum and embryo extract components of the medium 
were omitted, and the bottles supplied  at the usual intervals with a  100 per 
cent amniotic fluid  medium containing the standard concentration of anti- 
biotics, soybean trypsin inhibitor, and phenol red. At each change  of nutrient 
fluid, the medium harvested from a group of bottles was pooled and stored at 
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tinued slow extension of the specific cytopathic process. Uuinoculated control 
SM cultures were handled concurrently in the same manner. 
While unconcentrated fluids from these infected cultures showed minimal 
specific antigenic activity, a satisfactory CF antigen was obtained after con- 
cent.ration. Six V and Z antigens were thus prepared.  Three of these were used 
extensively and pertinent details regarding  their preparation are summarized 
in Table I. For example, the Wel. V antigen (Experiment 307A) came from 6 
tots of fluid totaling 1255 ml. and harvested between the 27th and 48th day 
after inoculation of the  bottles.  This particular material was  concentrated 
25.1X;  antigens prepared  subsequently were  likewise adjusted  as  to  final 
volume with veronal buffer to the same concentration. After a period of storage 
TABLE I 
•  Summary of PreParation of Varicella and Zoster Antigens from Infected Roller Bottle Cultures 
of Human Embryonic SM Tissue 
Exp. ]?~'o. 
307A 
399A 
400A 
Virus inoculum for bottle cultures 
Wd. V strain (0.3 ml. tissue sus, 
pension  from 21st  day,  13th 
TC passage cultures) 
Pat. V strain (0.4 ml. tissue sus- 
pension  from  llth  day,  8th 
TC passage cultures) 
Blu. Z strain (0.4 ml. tissue sus- 
pensio  n  from  34th  day,  7th 
passage cultures) 
Day after 
inoculation 
nutrient 
medium 
altered to 
bovine 
anmiotic 
fuid 
23rd 
llth 
11th 
Days fluid 
harvested 
and pooled 
27, 30, 34, 
38, 43, 4~ 
16, 19, 23, 
25, 29 
16, 19, 23, 
25, 29 
Volume 
.I~led 
rinds before 
concen- 
tration 
rnt. 
1255 
813 
698 
volume 
mL 
5O 
23.4  (ad- 
justed 
to 32.4) 
23.8  (ad- 
justed 
to 27.8 
in  the  frozen  state,  the  concentrates were  thawed, and centrifuged for  15 
minutes at 2000 R.P.M.; the supernatants, appropriately diluted, constituted 
the antigens. 
Characteristics of the Concentrated AntQens.--Complement  titrations done 
in the presence of doubling dilutions of the antigens heated 30 minutes at 60°C. 
indicated that the viral material possessed slight anticomplementary activity; 
the control material after such treatment was strongly anticomplementary. A 
second period of heating further reduced this undesirable property in the viral 
antigen but did not affect that of the concentrate from control uninoculated 
cultures  (see Table II).  This phenomenon was  observed  subsequently with 
another "control" antigen and a  satisfactory concentrate of control culture 
fluids  was riot obtained. The concentrated viral antigens were heated as routine 
twice before use. TABLE II 
Titration of Complement in the Presence of Dilutions  of  Antigen Concentrates Previously Heated 
Twice for 30 Minutes at 60°C. 
Antigen concentrate and dilution 
Pat. V  Antigen 
(399A) 
Corn dement dilution 
1:56  1:70  1:88  1:110  1:138  1:173  1:216  1:270 
1:2  ....  4-*  4-  +  + 
1:4  ......  4-  + 
1:8  .......  + 
1:16  ......  4-  + 
1:32  ......  4-  + 
1:64  ......  4-  + 
Blu. Z Antigen 
(400A) 
1:2  ....  4-  +  +  + 
1:4  .....  4-  4-  + 
1:8  ......  4-  + 
1:16  ......  4-  + 
1:32  ......  4-  + 
1:64  ......  4-  + 
Zoncentrate  from  1:2  +  +  +  +  +  +  +  + 
uninoculated con-  1:4  -  4-  +  +  +  +  +  + 
trolbottlecultures  1:8  --  --  4-  4-  +  +  +  + 
1:16  --  --  --  4-  +  +  +  + 
1:32  ....  4-  +  +  + 
1:64  ....  .4-  +  +  + 
*  4-, approximate  50 per cent end point;  --, more than  50 per cent hemolysis. 
TABLE ILl 
Block  Titration, in CF Tests of Varicdla  Antigens  (307A and 399A), Zoster Antigen (400A) 
and Convalescenl Varicdla  Serum  (164gB) Collected on 13th Day of Illness 
Antigen and 
dilutions thereof 
Wd. V307A  1:2 
1:4 
1:8 
1:16 
1:32 
Pat.  V399A  1:2 
1:4 
1:8 
1:16 
1:32 
Blu. Z400A  1:2 
1:4 
1:8 
1:16 
1:32 
1:4 
+ 
+ 
4- 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
4- 
Dilutions of convalescent v&ricelh serum 
(16OB) 
1:8 
+ 
+ 
+ 
+ 
+ 
4- 
+ 
+ 
+ 
1:16 
+ 
+ 
+ 
+ 
+ 
m 
+ 
+ 
..4- 
1:32 
+ 
+ 
+ 
.4- 
+ 
+ 
1:64 
+ 
+ 
+ 
-4- 
+ 
+ 
1:128 
.4- 
4- 
+ 
+ 
1:256 
m 
m 
w 
I 
m 
+ 
-4- 
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TABLE IV 
CF Antibody Response in Patients with Varicella and Herpes Zoster " 
as Assayed with Three Antigens 
Patients 
with vari- 
celia 
Patient No. 
11 
94 
316 
924 
1527 
1555 
1583 
2478 
2479 
Age 
yrs. 
18 
19 
16 
Day illness 
serum collected 
2 
15 
35 
Patients 
with 
herpes 
zoster 
2558 
1569 
16 
2 
11 
24 
5 
45 
2 
4 
17 
51 
2 
33 
4 
16 
28 
25 
<0 
32 
<0 
66 
2 
10 
85 
5 
28 
Complement-fixing  titer with concentrated 
fluid antigen 
Wel. V 307A 
<4 
64 
32 
<4 
128 
64 
<4 
128 
<4 
128 
<4 
4 
64 
16 
<4 
64 
<4 
256 
<4 
16 
64 
4 
128 
4 
64 
Pat. V 399A 
<4 
64 
<4 
64 
<4 
128 
<4 
128 
<4 
64 
<4 
32 
<4 
128 
64 
4 
32 
Blu. Z 400A 
<4 
64 
<4 
64 
<4 
32 
<4 
128 
<4 
32 
64 
<4 
32 
<4 
32 
<4 
256 
8 
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Patients 
with 
herpes 
zoster 
---Cont. 
Patient No.  Age 
1593 
1652 
1693 
1994 
2004 
2510 
2558 
44 
67 
27 
27 
85 
15 
25 
Day illness 
;erum collected 
1 
10 
33 
2 
15 
17 
99 
240 
3 
10 
4 
22 
2 
10 
85 
Complement-fixing  titer with concentrated 
fluid antigen 
Wel. V 307A 
512 
256 
32 
64 
4 
64 
8 
64 
128 
Pat. V 399A 
<4 
512 
256 
128 
16 
32 
<4 
128 
64 
Btu. Z 400A 
<4 
512 
512 
256 
16 
64 
8 
64 
16 
32 
64 
16 
128 
(4 
256 
Block titrations were performed to determine  the potency of the antigens 
using  an  arbitrarily  selected  sample  of  convalescent-phase  varicella  serum 
(Table III). The three antigens, in view of the findings, were used as routine 
in a  1:2 dilution. 
Complement-Fixing Antibody  Response in  Varicdla  and  Herpes Zoster as 
Assayed with Antigens Prepared  from Concentrated Culture Fluids.--Representa- 
tive results obtained with the three antigens in complement fixation tests on 
serum specimens collected from individuals with varicella or herpes zoster are 
tabulated in Table IV. This  table summarizes tests  done at different  times on 
specific  sera. It is to be noted that consistent and quite similar titers were  ob- 
tained with the three antigens. 
An indication of the temporal relationship between CF titer and the appear- 
ance of the exanthem in varicella and herpes zoster was provided by summariz- 
ing the titers as determined with the Pat. V antigen on 137 sera collected at 
various times from 52 individuals with varicella (see Text-fig. 1) and with the 
same antigen on 53 sera from 29 cases of herpes zoster (Text-fig. 2).  Patients 
with  varicella  usually  developed  demonstrable  levels  of  CF  antibody about 876  SEROLOGIC  STTJ-DIES  OF  VARICELLA  AND  ttERPES  ZOSTER 
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Interval  serum  collected  after  appearance  of  exanthem 
"I~xT-FIG,  1.  Complement-fixing titers as determined for 137  sera with Pa~.  V antigen; 
the specimens were obtained at various intervals after appearance of the eruption from 52 
individuals with variceUa. 
4-,  .u 
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1:8 
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Herpes  zoster 
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Interval  serum  collected  after  appearance  of  exanthem 
TExT-FIG.  2.  Complement-fixing titers as determined for 53  sera with Pat. V  antigen; 
the specimens were obtained at  varying intervals from 29  individuals with herpes zoster. 
the 4th or 5th day after the exanthem appeared, and during the 2nd week of 
illness  continuing and significant rises  in titer were the rule. The order of in- 
crease in titer observed on the examination of 37  paired sera is indicated in 
Table V. The initial serum specimen from patients with herpes zoster at times T.  H.  WELLER  AND  H.  M.  WITTON  877 
possessed significant levels of CF antibody and further increases in tiler, while 
frequently observed, did not always occur (Table V). Otherwise, the antibody 
pattern, as determined from a limited  number of sera, resembled that established 
for varicella. 
The data obtained by means of the multiple examination of individual serum 
specimens  with the different antigens were tabulated to obtain information 
on relative antigenic activity in the presence of sera from the homologous and 
heterologous  clinical  entities. This information is  summarized  in Table  VI, 
TABLE V 
Change in CF Tiler Observed during Convalescence on Examination of Paired Sera witk 
Wel. V, Pat. V, or Blu. Z Antigens 
Clinical entity 
rariceUa 
terpes zoster 
Ierpes simplex 
~eneralized 
vaccinia 
I  No  of pairs 
sera-tested 
37 
17 
13 
4 
No change 
in tlter 
0 
5 
11 
4 
Rise  in titer 
2X  [  4X  8X  15X  I  s2x  ~x  128X 
I 
3  3  3  6  10  8  4 
2  2  3  2  1  --  2 
1  1  ..... 
TABLE VI 
Comparison  of CF Tilers Obtained on Sera Examined Using Antigens Prepared  with Varicella 
Strains and with a Zoster Strain 
Clinical entity  sera derived 
No.  of sera 
tested with 
both V and Z 
antigens 
Comparison of CF titers obtained with antigen from the two 
sources 
2-fold  4-fold  S-fold 
Same  difference  difference  difference 
Varicella  23  16  5  2  0 
Herpes zoster  43  23  18  2  0 
and confirms the initial impression that the reactive capacity of the two types 
of antigen was similar in the presence of sera from cases of varicella or herpes 
zoster. The Blu. Z antigen tended to yield slightly higher titers with sera from 
either entity; thus, higher levels with Blu.  antigen accounted for 15  of the 
minor discrepancies recorded in Table VI with zoster sera, and for 5 of those 
with varicella sera. 
A small number of CF tests with the V-Z antigens were run on paired sera 
from patients with two other viral  diseases  manifested by vesiculopustular 
lesions (see Table V). The paired herpes simplex sera were known to contain 
specific complement-fixing  antibody and  were  derived almost equally from 
primary infections (acute herpetic gingivostomatitis) and from recurrent infec- 878  SEROLOGIC STUDIES OF VARICELLA AND HERPES  ZOSTER 
tions. The single instance of a 4-fold increase in titer was noted on examination 
of paired sera from a 23 year old man with a clinical diagnosis of herpes labialis. 
Using Wel. V. antigen, the CF titer was 1:4 in a specimen collected as lesions 
developed, and was 1:16 in a specimen collected 13 days later; both sera re- 
acted to a titer of 1:16 with a herpes simplex antigen. Five of the six pairs of 
sera  from primary herpetic infections  in small children and four pairs from 
infants with generalized vaccinia did not fix complement in the presence  of 
V-Z antigens in dilutions beyond 1:4. 
Preparation of a Varicella Complement-Fixing Antigen from Infected Cultures 
of Monkey Kidney  Tissue.--In an experiment  performed by Dr.  E.  J.  Bell, 
bottle cultures of monkey  kidney tissue were used for the preparation of antigen. 
Six 13 day bottle cultures of trypsinized rhesus kidney tissue were inoculated 
with 1.0 ml. amounts of infected tissue suspension from the 7th passage  Ore. 
V line in FS roller tubes. Five bottle cultures similarly received 1.0 ml. amounts 
of ground tissue  from the comparable  Ore. control cultures.  Extensive focal 
lesions involving approximately 20 per cent of the outgrowth developed by the 
llth day in the infected bottles; the medium was changed to amniotic fluid 
without serum or extract on that day, and subsequently, changes of medium 
and harvests were made on the 14th,  18th,  21st, and 25th days. One control 
culture showed  changes  compatib]e  with monkey "foamy"  virus  and  these 
fluids were discarded.  The pooled virus and control fluids were concentrated 
10 times by filtration. 
Subsequently,  the antigens were heated for 30 minutes at 56°C. and comple- 
ment titrafions then performed  in the presence of doubling dilutions thereof; 
in this instance neither the viral nor the control antigen was anticomplementary 
in a  1:2  dilution. The V antigen from monkey cultures was compared  with 
the Wel. and Pat. antigens of human culture origin in three CF tests (see Table 
VII). The varicella  antigen from monkey kidney material appeared slightly 
less potent but gave equivalent results. 
Complement-Fixing Activity of Extracts of Human  Tissue Suspensions from 
Infected Bottle Cultures.--It  was determined in one experiment  that a  satis- 
factory antigen could be prepared from the tissue phase of infected cultures. 
The tissue  suspensions were obtained from the bottle cultures  of SM tissue 
infected with Pat.  or B/u.  virus which were used  for the production of the 
fluid antigens.  These cultures were terminated on the 29th day after inocula- 
tion when approximately 90 per  cent of the tissue  was involved.  Following 
removal  of the nutrient fluid, 5 ml. of veronal buffer were added per bottle, 
the tissue was scraped,  and the resulting  suspensions were pooled and frozen 
at  -20°C.  Tissue  was  similarly  harvested  from  the  control  bottles.  Nine 
months later the material was twice quickly thawed and frozen, and thereafter 
centrifuged at 2000 I~.P.M. for 15  minutes. The supernatant constituted the 
antigenic material and was  stored in the frozen  state until used.  After the T.  H.  WELLER  AND  H.  M.  WITTON  879 
antigens were heated 30 minutes at 56°C.,  block fitrafions  of complement in 
the presence  of dilutions of control tissue extract and of the B/u. Z  and Pat. 
V  extracts  were performed;  the results  indicated that the end point of anti- 
complementary  activity  was  of  the  order  of  1:4  to  1:8.  Therefore,  after  a 
second inactivation, the tissue extracts were used as antigens in a  1:16 dilu- 
tion. In a  limited series  of CF  tests,  the control tissue antigen did not react 
with paired zoster sera.  The Blu.  Z  and Pat.  V  tissue extract  antigens gave 
results  comparable  to  those  obtained  in  the  concurrent examination  of  the 
same sera with the Pat. concentrated fluid antigen which was used, as routine, 
in a  1:2  dilution. 
TABLE VII 
Representative Results in CF Tests on  Varicdla Sera Wherein V and Control Antigens from 
Monkey Kidney  Cell Cultures Were Compared with Two V Antigens 
from Human Culture Sources 
Antigen 
Wel.-Hu. V 
Orc.-Monk. V 
Monk. Control 
Wd.-Hu. V 
Orc.-Monk. V 
Monk. Control 
Pat.-Hu. V 
Ore.-Monk. V 
Pat.-Hu. V 
Ore.-Monk. V 
i Serum No. and 
day collected 
1649A-3rd 
ca  4c 
1649B-13th 
78A-2nd 
78B-33rd 
cl  ~c 
Serum dilutions 
+ 
+ 
m 
16  32 
+  + 
+  -4- 
+  + 
+  + 
64  128  256 
+  4-  - 
+  ±  -- 
512 
m 
n 
m 
The Development of in Vitro Neutralization Procedures with the V-Z 
Viruses 
Preliminary  Studies.--Initial attempts at demonstration of specific neutrali- 
zation of the cytopathic activity of the V-Z viruses progressed along classical 
lines. Virus, in the form  of a suspension of fragments of the infected cell sheet, 
was  incubated  for  1  hour at  5°C.  with  aliquots  of  convalescent  phase  sera; 
the  sera  were known to react  specifically  when  examined  by  the fluorescent 
antibody or CF  procedures.  The  inoculation of  actively  growing cultures  of 
SM  tissue  with  convalescent  phase  serum-virus  mixtures  resulted  in  little 
inhibition of the focal process as compared to the development of focal lesions 
in control cultures receiving a virus inoculum. 
Actively growing SM cultures were then selected,  and just prior to inocula- 
tion the medium was modified by the addition of acute or convalescent vari- 880  SEROLOGIC  STUDIES  OF  VARICELLA  AND  HERPES  ZOSTER 
cella serum in a final concentration of 5 per cent. The incubation of virus with 
serum was omitted.  After inoculation,  the medium containing human serum 
was left in  the cultures until  the first fluid change 3  days later; it was then 
replaced  by the regular nutrient.  No significant  difference was noted in  the 
number of focal lesions  appearing in  the  different  groups  of cultures  (Table 
VIII) although  the foci in cultures  exposed to the convalescent phase serum 
appeared to spread more slowly. A  definite effect was noted,  however, when 
the serum concentration was increased to 10 per cent. In one experiment, ali- 
quots of acute and convalescent phase zoster sera were thus incorporated in 
the medium for a  period of 5  days before to 2  days after inoculation of the 
cultures. As summarized in Table IX, both zoster sera appeared to have defi- 
nite, but limited inhibitory activity. 
TABLE VIII 
Neutralization  Experiment  Wherein  Acute and  Convalescent Var~eUa Sera  in a 5 Per Cent 
Concentration Were Incorporated as Constituents of the Culture Medium for the 3 
Day Postinoculation Period* 
Group of cultures 
Virus control (Wel. V strain; llth TC passage) 
Wd. virus +  "V" acute phase serum (No. 1006A 
--lst day illness) 
Wel. virus +  "V" convalescent serum (No. 1006C 
--23rd day) 
Average No. of focal lesions per culture or per 
cent of cell sheet involved on day:$ 
4  7 
2  9.1 
5  11 
3.1  7 
10 
12% 
25% 
8% 
* Human serum omitted from medium on day 3. 
~: Based on 3  cultures per group. 
Neutralization  Tests Wherein Serum Specimens  Were Incorporated  as a  Con- 
tinuing Constituent of the Culture Medium.--As the result of these observations 
a neutralization technique evolved based on the long term incorporation of the 
sera under examination in the culture medium. Two series of experiments were 
conducted; in the first of these, virus was incubated with serum in the custom- 
ary manner prior to inoculation, while in the second set virus was added with- 
out prior treatment directly to the serum-containing cultures. 
In  the  first group  of experiments,  evidence was  obtained  that  cytopathic 
activity of the V and Z viruses was inhibited by sera deriving from the homol- 
ogous  and  the  heterologous  clinical  entities.  In  these  experiments,  acute  or 
convalescent phase sera were added in a  10 per cent concentration to freshly 
prepared suspensions  of infected tissue from cultures  and  the mixtures kept 
at  4°C.  for 1 hour;  a  third  aliquot of tissue was similarly handled  after the 
addition of media in a  10 per cent concentration and constituted the inoculum T.  H.  WELLER  AND  H.  M.  WITTON  881 
for the virus control cultures. Meanwhile, cultures of SM tissue were examined 
to confirm the existence of active growth and were usually divided into three 
groups; the regular medium was removed from two sets of cultures and re- 
placed with media incorporating in a  10 per cent concentration the respective 
sera under examination. The cultures were then inoculated with 0.2 ml. amounts 
of the virus or serum-virus suspensions. At the first change of nutrient fluid, 
usually on the 4th or 5th day after inoculation, fresh medium containing a  10 
per cent concentration of the serum under test was added. In some of the ex- 
periments,  all cultures thereafter were shifted to regular medium  (about the 
9th day) while in others a  second or third addition of serum-containing media 
was carried out. The virus control group was maintained  on regular medium 
TABLE IX 
Experiment Wherein Acute and Convalescent Human Sera Were Incorporated in a I0 Per Cent 
Concentration in the Culture Medium during the Period 5 Days before ~o 
g Days after Inoculation*, 
Group of cultures 
Bag. Z. virus control 
Bag. virus +  Z acute phase serum 
(No, 2510A---4th day) 
Bag. virus +  Z convalescent  serum 
(No, 2510B--22nd day) 
Average number focal lesions or per cent  tissue involved per 
culture as observed on day:§ 
417 
<1  4.5  11.5  01  0  0  2.5 
13 
s~ 
7% 
s% 
16 
60% 
9s% 
90% 
* Virus (Bag. Z strain, 14th passage) not incubated with serum; added as 0.1 ml. infected 
tissue suspension. 
:~ Human serum removed from medium on day 2. 
§ Based on two cultures per group. 
throughout. The cultures were examined microscopically at frequent intervals; 
at each observation an attempt was made to survey the entire cell sheet and 
to record the number of focal lesions per culture. 
Although there was a striking delay in the appearance and in the number of 
lesions developing in cultures containing convalescent phase sera, in no instance 
was  complete neutralization of cytopathic activity observed. The pattern of 
response of varicella virus cultivated in the presence of sera from a  varicella 
patient is summarized in Table X; in Table XI are presented results of two 
experiments wherein V virus was cultivated in the presence of Z  sera and Z 
virus with V sera. The cytopathic activity of the V and Z viruses was inhibited 
in the presence of convalescent phase sera from either entity. The findings also 
suggested that the acute phase zoster serum collected on the "lst day" of ill- 
ness  possessed  a  greater  degree  of inhibitory activity than  the  comparable 882  SEROLOGIC  STUDIES 0]?  VARICELLA AND  HERPES ZOSTER 
varicella serum collected on the 3rd day of illness. That high levels of inhibitory 
activity could develop in an individual with varicella by the 7th day of illness 
was shown in another experiment wherein sera (No. 1582) collected on the 7th, 
19th, and 34th day of illness were examined with the Rob. V virus; on the 11th 
day, the average number of loci respectively in the three groups of serum cul- 
tures  was  1.0,  0.3,  and  1.6,  while  the  virus  control  cultures  contained  an 
average of 36 lesions per tube. 
The inhibition of virus by convalescent phase serum from the heterologous 
clinical entity was a regular finding. The pair of varicella sera (No. 1550) used 
with Blu.  virus, for example, were also examined with another zoster strain 
(Bag.).  Similar results were obtained; the average number of loci in cultures 
on the 7th day after inoculation was 44 in the virus control tubes, 36 in cultures 
TABLE X 
Neutralization Test with Human Sera Incorporated as a Constituent of the Medium for 8 Days 
after Inoculation. (McEl.  V Virus; Varicella, Acute and Convalescent Sera)* 
Group  of cultures 
McEl. virus control 
McF-J. virus +  V acute serum 
(334A--4th day) 
McEI.  virus +  V convalescent 
serum  (334B--11th  day) 
No. focM lesions or per ¢*~t tissue involved per culture as observed 
on day:$ 
I  l_k_0  14 
0.3  1  7.2  13  18  46  35% I 55% 
0  0.3  5  7  9  24  25°/0  55°/0 
0  [  0  0  0.3  0.6  1.6  3  7 
* Shift from media containing human sera to routine medium on 9th day. 
Average of 3 cultures per group. 
with acute phase serum and 1.2 in the four cultures containing serum collected 
on the 13th day of illness. 
The focal lesions that developed in the presence of convalescent phase sera 
were smaller in size and progressed less rapidly than did comparable loci in con- 
trol cultures. In addition, they were often morphologically distinct, appearing 
relatively opaque and frequently the involved cells were associated with granu- 
lar debris. This, in part, appeared to be the result of continuing degeneration 
of infected cells with concurrent partial inhibition of the usual process of in- 
fection of contiguous cells.  It is possible  that some of the observed granula- 
tion reflected the occurrence of an "in vitro" precipitin reaction, but no defini- 
tive information was obtained on this point. The phenomenon of granulation 
of the focal process was also observed with acute phase zoster sera that were 
inhibitory; the phenomenon is depicted in Fig. 1 and may be compared with 
the usual lesion in the control cultures shown in Fig. 2. 
The repetitive addition of aliquots of human serum to the cultures in the T.  H.  WELLER AND H.  M.  WITTON  883 
neutralization  procedure introduced practical problems,  including that of the 
cytotoxicity of some of the stored samples of serum.  It is found desirable  to 
pretest  human  sera  for cytotoxicity; this  was  done  by maintaining  pairs  of 
cultures of SM or FS tissue for 6  to 8 days with media containing the serum 
under  test  in  a  10 per  cent concentration  during  which  time  one  change of 
TABLE XI 
Neutralization Experiments with V and Z Viruses and Paired Sera from 
the Heterologous Clinical Entities 
Group of cultures 
No. focal lesions or pee cent tissue involved per culture as observed 
on dsy::~ 
2  4  5  6 
Exp. 532A; Varicella virus 
and zoster sera 
Wd.  V  virus  control  0.5  10.2  10.5 
(17th TC pass.) 
Wd. V virus +  Z acute  0  4.7  6.5 
serum  (1762A--1st 
day) 
Wd. Vvirus+Zcon-  0  0.5  0.7 
valescent  serum 
(1762B--22nd  day) 
Exp.  549A;  Zoster  virus 
and varicella sera 
Blu.  Z  virus  control  9.2  13.5 
(10th TC pass.) 
Blu. Z virus +  V acute  4.7  12.4 
serum  (1550A--3rd 
day) 
Blu.  Zvirus +  Vcon-  0.7  1.2 
valescent  serum 
(1550B--lOth  day) 
7  9  1!  12  17 
14.2  19.5  26.5  25% 
6.7  7.5  8.0*  16°/o 
0.7  1.0  2.2*  3.0 
22%  s1% 
35%  52%* 
13  15.5" 
* Time cultures  shifted to routine  medium. 
Four cultures per group in each experiment. 
nutrient was made. Those sera possessing an inhibitory effect on tissue growth 
were not subsequently examined for virus-neutralizing  capacity. 
In the second group of experiments,  incubation of the virus-serum mixtures 
prior to their inoculation into cultures was omitted.  Two cross-neutralization 
experiments  were  performed  using  serum  dilutions  in  a  further  attempt  to 
determine  if  immunologic differences  in  behavior could  be  demonstrated  for 
the V  and Z  viruses. In the first of these, doubling dilutions in media, starting 
with a  1 : 10 dilution, were made with sera (No. 2510 A and B) obtained on the 
4th  and  22nd day of  illness  from a  15-year-old boy with  herpes  zoster; this 884  SEROLOGIC  STUDIES  OF  VARICELLA  AND  HERPES  ZOSTER 
patient had a history of varicella as a child. The serum dilutions in media were 
used to refeed groups of cultures of SM tissue.  Nineteen hours later,  part of 
the roller cultures were inoculated with 0.1  ml. aliquots of a  freshly prepared 
TABLE XII 
Neutralization  Experiments  with  V  and Z  Slrains and Dilutions  of Paired  Zoster  and 
Varicella Sera; No Incubation  of Virus-Serum  Mixtures* 
Average No. of focal lesions 
Group of cultures  per culture observed on day:  Group of cultures 
McEl. V virus control 
Average No. of focal lesions 
per culture observed on day: 
3141,T018  o  10  3  4  s  ,  8 
7  18  35  64  122  Bag. Z  virus control  6  18  30  51 
McEL  V  virus  and  Z  Bag.  Z  virus  and 
acute serum (2510A)  Z acute serum 
(2510A) 
Serum dilution 1:I0  <1  1  1  1  7  Serum dilution 1:10  0  0  2  3  3 
"  "  1:20  1  4  5  6  9  "  "  1:20  4  6  6  11  12 
"  "  1:40  5  5  8  13  22  '¢  "  1:40  5  15  13  26  i  45 
"  "  1:80  6  11  16  40  66  "  "  1:80  6  10  19  37  I 67 
McEI.  V  virus  and  Z  Bag. Z virus  and Z con-  ] 
convalescent serum  valescent serum 
(2510B)  (2510B) 
Serum dilution 1:10  0  0  0  <1  2  Serum dilution 1:I0  0  0  0  <I  0 
"  "  1:20  1  2  2  4  4  "  "  1:20  0  <1  1  2  i  8  i 
"  "  1:40  2  4  4  i  13  14  "  "  1:40  <1  3  $  10  15 
"  "  1:80  3  6  9  16  19  "  "  1:80  7  8  13  22  37 
33  31  McEI. V virus control 
McEI.  V  virus  and  V 
acute serum 
(l161A) 
Serum dilution 1:10 
"  "  1:20 
23  37  80  M 
8  10  46  63 
4  6  31  ND 
<I  3  9  23 
1  8  20  43 
2  9  29  71 
Bag. Z virus control  58  M 
Bag.  Z  virus  and  V 
acute serum 
(l161A) 
Sermn dilution 1:10  9  16  32  57 
"  "  1:20  11  22  ND  ND 
Bag.  Z  virus  and  V 
convalescent 
serum (l161B) 
Serum dilufion 1:10  2  6  6  14 
"  "  1:20  4  14  34  58 
"  "  1:40  11  15  36  72 
McEl.  V  virus  and  V 
convalescent serum 
(l161B) 
Serum dilution 1:10 
4.  "  1:20 
"  "  1:40 
M, many  focl; not counted.  ND,  not done. 
* Serum kept in medium throughout experiment. 
suspension  of infected  tissue from 19-day cultures  of 25th  passage McEI.  V 
virus, and part with similar material from 16-day-old cultures of 15th  passage 
Bag.  Z  virus. Three cultures were used in each virus control group,  and  two 
cultures for each serum dilution.  The cultures were refed twice and serum  in 
appropriate dilution kept in the system through the 10th day. The results  are 
summarized in Table XII. In a  second experiment the  same procedure  was T.  H.  WELLER  AND  H.  M.  WITTON  885 
used to examine paired varicella sera collected on the 2nd and 49th day of ill- 
ness, with the exception  that the V and Z viruses  were 26th  passage  McEl. 
and 16th passage Bag. materials, each harvested on the 13th day of cultivation 
(see Table XII). The results again indicated that a close serologic relationship 
existed between the V and the Z strains tested. Both acute phase sera, particu- 
larly that from the zoster case, had an inhibitory action on the development of 
the focal lesions. The CF titers of the pair of zoster sera were 1 : 16 and 1 : 128 
respectively, and of the varicella pair were 1: 4 and 1: 64. 
DISCUSSION 
We have previously presented data indicating that the viruses  of varicella 
and herpes zoster have been propagated in cultures of various tissues of human 
and of monkey origin. The demonstration that the V and Z viruses  produce 
antigenic materials in ~itro capable  of binding complement in the presence of 
convalescent  phase sera from patients with varicella or herpes zoster, and the 
further finding that such  sera are capable  of specific inhibition of V-Z viral 
cytopathogenicity, provide additional evidence  that we are dealing  with the 
etiologic agents. Indeed, together with the information previously accumulated 
by the fluorescent antibody method (6), the body of serologic data now appears 
to afford an incontrovertible documentation in support of this thesis. 
The question of the relationship of the viruses of zoster and of vancella has 
been widely discussed since 1888 when yon Bokay observed  that on occasion 
susceptible  individuals developed  varicella  following  contact  with  patients 
who had herpes  zoster (13). In support of von Bokay's hypothesis,  various 
observations  have gradually accumulated indicating the close relationship,  and 
probable  identity, of the V-Z viruses.  It is to be noted, however,  that some 
experienced clinicians continue to question the monistic hypothesis (14). The 
data from the laboratory may be summarized as follows. As first described by 
Tyzzer (15) and Lipschiitz (16), the reaction at the cellular level produced by 
the V and Z viruses in man is similar. It is evident that this similarity extends 
to  the  cytopathic response  induced by  these  viruses  in  ~itro (7). Electron 
microscopic examination of vesicle fluid materials from both entities has indi- 
cated that the fluids contain bodies, interpreted as viral, that appear identical 
(17-19). Heretofore, immunologic studies have utilized vesicle fluid. In general, 
the results with vesicle fluid as a CF antigen have indicated a close relation- 
ship of the two entities (20, 2). Amies (4) recorded frequent cross-reactions in 
microagglufination  studies, although some variation occurred. Our complement 
fixation studies with the agents propagated in ~itro clearly confirm the exist- 
ence of common antigenic factors in the V and Z viruses. Further evidence of 
a  close relationship  is provided by the findings of the in vitro  neutralization 
experiments.  Yet, in view of the present limitations of the neutralization pro- 886  SEROLOGIC  STUDIES  OF  VARICELLA  AND  HERPES  ZOSTER 
cedure as dictated by the unusual behavior pattern of the V-Z viruses,  the 
possibility remains that subtle, and now undetectable, strain differences may 
exist. However, the accumulation of epidemiological and laboratory evidence 
in support  of the hypothesis that a  single etiologic agent is responsible for 
varicella and herpes  zoster appears  so impressive that  the burden  of proof 
must now logically shift to those who desire to refute the monistic concept. 
The CF procedure as herein described should, with minor modifications, pro- 
vide the diagnostic laboratory with a convenient technique for the diagnosis of 
two additional common clinical entities of viral etiology. In the CF experiments, 
the  difficulties encountered in the preparation  of a  suitable control antigen 
from fluid materials and the lack of a reference antiserum were an early source 
of concern. However, the negative results obtained with the control tissue ex- 
tract and monkey kidney culture antigens and the uniformity of the CF anti- 
body response in paired varicella sera gave assurance of the specificity of the 
reaction. The neutralization technique, as here used, is time-consuming and 
exacting; it will not find favor as a diagnostic procedure until simplified. 
Application of the complement fixation and neutralization reactions should 
provide a better understanding of the response of the human host to the V-Z 
viruses. In varicella, specific  CF antibody becomes demonstrable around the 
4th or 5th day after the appearance of the exanthem; Amies (3) observed that 
agglutinins appeared after a similar interval, as does antibody reacting by the 
fluorescent technique (6). As an example of an unusual situation, the failure of 
CF antibody to appear by the 12th day of illness in a  case of varicella with 
fatal outcome (21) provided serologic  evidence of a defect in host response. 
Relatively few sera were obtained immediately after the appearance of the 
eruption in patients with zoster;  some of these already contained significant 
levels of CF antibody. It is tempting to consider that these early antibody 
responses might be  a  reflection of previous experience with V  virus; on the 
other hand, they may reflect the existence of a long prodromal stage in an en- 
tity with an ill defined incubation period. The appearance of a  varicelliform 
eruption in the patient with herpes zoster is a  recognized complication. We 
obtained paired sera from 6 zoster patients who developed disseminated lesions. 
In four of these the CF antibody response was of the usual order, but in two, 
titers of 1:4 and 1:8 were recorded for sera collected on the 12th and 17th 
day respectively. Application of the new serologic  techniques should assist in 
elucidating the pathophysiologic mechanism of herpes zoster and its bizarre 
clinical manifestations. Almost certainly such an understanding will be based on 
a concept involving intracellular proliferation and persistence of the V-Z viruses 
in the presence of humoral antibody. The factors controlling transfer of the 
virus from cell to contiguous cell, both in vitro and in vivo, form a  challenging 
area for investigation of fundamental importance. T.  H.  WELLER AND H.  M.  WITTOlq  887 
SUMMARY 
The preparation of antigenic materials capable of specific fixation of comple- 
ment in the presence of convalescent phase sera from patients with varicella 
and  herpes  zoster is  described.  Satisfactory antigens  were  obtained  by the 
repetitive harvest and subsequent concentration of the pooled nutrient fluids 
from bottle cultures of human embryonic skin-muscle tissue or of monkey kid- 
ney tissue infected with varicella or herpes zoster viruses. Specific fixation of 
complement was  also demonstrated with antigens prepared from extracts of 
the infected cell sheets harvested from bottle cultures. 
In individuals with varicella, complement-fixing antibody usually appeared 
in the serum 4 or 5 days after the development of the exanthem and further 
significant increases in titer were characteristically observed during the  2nd 
week of illness. 
The complement-fixing antibody response in herpes zoster tended to follow 
the same pattern as in varicella, with the exception that in sera from some 
individuals relatively high  titers were present  in  the  acute phase  specimen. 
Complement-fixing antigens prepared from varicella strains or from a zoster 
strain reacted to essentially the same degree with convalescent sera from the 
homologous and  the  heterologous clinical entities.  The varicella-zoster anti- 
gens did not fix complement in the presence of paired sera obtained from a 
limited number of individuals with primary infections due to herpes simplex 
virus or from individuals with generalized vaccinia infection. 
Specific inhibition in dtro  of the focal cytopathic process produced by the 
varicella-zoster  viruses  was  demonstrated.  This  was  accomplished  by  the 
incorporation of the sera under test as constituents of nutrient media of the 
cultures,  either prior to or at  the  time of their inoculation with virus.  The 
neutralization of focal cytopathogenicity thus obtained was relative in degree 
and never absolute; it was therefore assayed by repetitive counts of the number 
of focal lesions per culture in the various test groups. 
Inhibition of varicella-zoster viral cytopathogenicity occurred in the presence 
of convalescent serum from either clinical entity. 
The results of the immunologic studies with the viruses of herpes zoster and 
varicella as propagated in vitro  are considered as providing further evidence 
in support of the concept of the close relationship and probable identity of the 
two agents. 
The authors  are indebted to many physicians who have provided clinical material or 
have contributed sera; and in particular to Dr.  J. J.  Finn, Jr., Dr. J. T. Heyl, and  Dr. 
Conrad Wesselhoeft. 
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EXPLANATION OF PLATE 62 
FIG. 1.  Granular appearance of small focal lesion produced by Bag. Z virus in  SM 
tissue as observed in presence of l0 per cent acute phase zoster serum (2510A) which 
was inhibitory (see Table XII). Zoster serum collected on 4th day after eruption. 
Bag. Z virus inoculum from 15th TC passage. Picture on 10th day after inoculation. 
X  136. 
FIG. 2.  Appearance of small focal lesion in culture of SM tissue inoculated with 
15th TC passage Bag. Z virus l0 days earlier. Virus control culture from neutralization 
experiment showing usual  appearance of focal cytopathic process. ×  136. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  108  PLATE  62 
(Weller and Witton: Serologic studies of  varicella  and  herpes  zoster) 